Cystic Fibrosis Clinical Trial
Official title:
Analyse Fonctionnelle Par Imagerie Dynamique de l'épithélium Respiratoire Chez Des Nourrissons Atteints de Mucoviscidose
Cystic fibrosis (CF) is characterized by airway inflammation and infection leading to progressive destruction of lungs. One of the most important abnormalities in CF is an abnormal processing of the mutated CFTR protein through the endoplasmic reticulum that causes abnormal location or even absence of the protein at the apical plasma membrane of airway epithelial cells. This abnormality results in a marked dehydration of the airway surface fluid, decreased mucus transport and airway obstruction. Nevertheless, the events that occur very early during the progression of the disease at the airway level in infants are not known. At cellular level, it has also been reported that the CFTR expression and localization could be related to the differentiation state of the airway epithelium. Furthermore, it has been reported that gap junctions could be involved in dysregulate inflammation process. In CF infants, many answers are still lacking. For a better understanding of the early stages of cystic fibrosis, it is of major interest to study respiratory epithelial cells obtained as early as possible. In 15 CF infants and 15 control infants, a nasal brushing will be performed by means of a soft sterile cytology brush. Samples will be used for cytological and functional studies: ciliary beating frequency, cAMP-dependent chloride efflux, potassium efflux, tight and gap junctions functionalities. These studies will be done in basal conditions and will be repeated after activation of the nasal epithelial cells by the bacteria, such as Staphylococcus aureus, which can be found very early in the course of CF disease.
Cystic fibrosis (CF) is characterized by airway inflammation and infection leading to
progressive destruction of lungs. One of the most important abnormalities in CF is an
abnormal processing of the mutated CFTR protein through the endoplasmic reticulum that
causes abnormal location or even absence of the protein at the apical plasma membrane of
airway epithelial cells. This abnormality results in a marked dehydration of the airway
surface fluid, decreased mucus transport and airway obstruction. Nevertheless, the events
that occur very early during the progression of the disease at the airway level in infants
are not known. At cellular level, it has also been reported that the CFTR expression and
localization could be related to the differentiation state of the airway epithelium.
Furthermore, it has been reported that gap junctions could be involved in dysregulate
inflammation process. In CF infants, many answers are still lacking.
Is inflammation present before infection? Is native epithelium of CF infants more sensitive
than controls? Could the investigators analyse the localisation and functionality of CFTR,
tight and gap junctions in respiratory epithelial cells in CF infants? Could the activation
of the epithelial cells by bacteria alter their functional properties? For a better
understanding of the early stages of cystic fibrosis, it is of major interest to study
respiratory epithelial cells obtained as early as possible. Although bronchoalveolar lavage
has been proposed for this purpose, nasal brushing, which is a much less invasive technique,
has seldom been used in CF infants. the investigators have shown that, by means of a simple
nasal brushing technique easily performed and well tolerated, it is feasible, in infants, to
harvest native respiratory cell sheets in order to analyse the airway epithelium
functionality. In 15 CF infants and 15 control infants, a nasal brushing will be performed
by means of a soft sterile cytology brush. Samples will be used for cytological and
functional studies: ciliary beating frequency, cAMP-dependent chloride efflux, potassium
efflux, tight and gap junctions functionalities. These studies will be done in basal
conditions and will be repeated after activation of the nasal epithelial cells by the
bacteria, such as Staphylococcus aureus, which can be found very early in the course of CF
disease.
the investigators believe that the present study could help to understand the
pathophysiology on the very early stages of CF disease.
;
Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
| Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
| Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
| Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
| Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
| Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
| Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
| Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
| Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
| Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
| Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
| Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
| Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
| Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
| Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
| Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
| Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
| Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |